Form 4: Integra LifeSciences Executive Reports Stock Disposal
SEC Form 4 Filing
Robert T. Davis Jr., EVP & President, TT of Integra LifeSciences Holdings Corp, disposed of 592 shares of common stock on March 10, 2025, to cover tax obligations.
Summary
- On March 10, 2025, Robert T. Davis Jr., an Executive Vice President and President, TT at Integra LifeSciences Holdings Corp, disposed of 592 shares of common stock.
- The transaction was executed at a price of $22.61 per share.
- Following the transaction, Davis directly owns 64,515 shares of Integra LifeSciences Holdings Corp.
- The disposal was related to covering tax obligations.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to stock transactions by an executive. It doesn't inherently convey positive or negative sentiment about the company's performance.
Industry Context
Form 4 filings are standard disclosures required by the SEC to ensure transparency in trading activities by corporate insiders. They provide insights into the actions of key executives and their confidence in the company's prospects.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it involves a small number of shares being disposed of by an executive.
Key Dates
| Date | Description |
|---|---|
| 03/10/2025 | Date of stock disposal transaction |
| 03/11/2025 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.